Diagnostic imaging contrast agents with extended blood retention
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 13, 2011
Grant Date -
Jan 4, 2007
app pub date -
Jun 22, 2006
filing date -
Feb 1, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully